« Return to News | CROs/Service Providers

PatientsLikeMe, inVentiv Health partner to accelerate research

Wednesday, June 19, 2013 01:58 PM

CRO inVentiv Health is partnering with online patient network PatientsLikeMe, which has 200,000 members who share information and experiences on more than 1,500 different diseases and conditions, to bring people more quickly into medical research and clinical trials.  

"inVentiv Health will be able to quickly recruit potential trial participants by tapping into one of the fastest growing and most active patient networks online, so that our customers can speed up the development of drugs, devices and treatments to improve patients' lives," said Raymond Hill, president of inVentiv Health.

"We've pioneered a way for people to learn from, share and contribute health data, and removed traditional barriers between researchers and patients," said Michael Evers, executive vice president of marketing and patient advocacy at PatientsLikeMe.

This agreement is inVentiv's third recent partnership focused on accelerating clinical trials. In March, it took an equity stake in Mytrus, which has been expanding the boundaries of traditional clinical trial research with technology that allows sponsors to use electronic informed consent.  In early June, it announced a partnership with Medikly to gather data, enabling faster recruitment of clinical trial investigators.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.